Med Business World

Your source for healthcare business

Sofie Larsen

Snorles GenioFlex: The Innovative Daytime Solution for Snoring Management Now Launched on Indiegogo

Snorles, a leading innovator in sleep technology, is excited to announce the launch of its latest product, GenioFlex. Snorles created to address snoring issues and promote overall health and well-being, GenioFlex offers a fresh approach to managing snoring without the…

Cenegenics Partners With Exoceuticals® to Incorporate Cutting-Edge Exosome-Formulated Skincare Into Holistic Health Practices

Cenegenics, a global leader in personalized healthcare, is partnering with Exoceuticals®, a pioneering skincare company at the forefront of regenerative and exosome-formulated skincare. This collaboration signifies Cenegenics’ unwavering commitment to providing its clients with the most innovative and comprehensive health and…

A pioneering two-day workshop in Bangalore to understand how climate change and caste and gender discrimination can make infections harder to treat

The One Health Trust, funded by the World Health Organization and the British Academy, hosted a two-day workshop focused on developing inclusive policy recommendations for our changing world. The workshop highlighted the urgent need to address antimicrobial resistance (AMR), which…

Philips and AWS collaborate to scale digital pathology in the cloud, enhancing diagnostic capabilities and improving productivity

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced an expanded collaboration with Amazon Web Services (AWS) to address the growing need for secure, scalable digital pathology solutions in the cloud. The collaboration unites Philips’ leadership…

Solera and Aon Collaborate to Offer Employers Curated Network of Digital Health Solutions and Analytics for Clinical Outcomes and Cost Savings

Solera Health, the premier technology platform for connecting people seamlessly and easily to health solutions that work, today announced a collaboration with Aon (NYSE: AON), a leading global professional services firm. This joint effort helps more employers deliver personalized employee…

vTv Therapeutics Announces FDA Submission for First Phase 3 Study of Cadisegliatin in Patients with Type 1 Diabetes

vTv Therapeutics Inc. (Nasdaq: VTVT), a clinical stage biopharmaceutical company focused on the development of cadisegliatin (TTP399) as an adjunctive therapy to insulin for the treatment of type 1 diabetes (“T1D”), today announced the submission of the study protocol to the FDA…

PCM Trials Acquires EmVenio Research to Create the Most Patient-Centric Model for Hybrid and Decentralized Clinical Trials

Denver-based PCM Trials, the largest independent mobile research nurse visit provider for decentralized clinical trials (DCTs), today announced the acquisition of EmVenio Research based in Durham, North Carolina. EmVenio is the largest provider of community-based clinical trial sites served with mobile research units. The…

PharmaTher’s Sairiyo Therapeutics Inc. Advances Clinical Development of Patented Reformulated Cepharanthine for Phase 1 Study in Australia

PharmaTher Holdings Ltd. (the “Company” or “PharmaTher”) (OTCQB: PHRRF) (CSE: PHRM), a specialty pharmaceutical company, announced today Sairiyo Therapeutics Inc. (“Sairiyo”), a company that is forty-nine percent (49%) owned by PharmaTher and fifty-one percent (51%) owned by PharmaDrug Inc. (CSE:…

Shamir Medical Center Reveals New Long-Term Results from Long COVID Study to Highlight Positive Impact on Symptoms Resulting from Hyperbaric Oxygen Therapy

Today, Aviv Clinics reveals results from the Sagol Center for Hyperbaric Medicine and Research at Shamir Medical Center and Tel Aviv University from a longitudinal long Coronavirus disease (COVID) study highlighting hyperbaric oxygen therapy (HBOT) as an effective treatment for those with long COVID…

IR-MED to Report New Clinical Efficacy Data for Detection of Pressure Injuries with its AI- Based PressureSafe™ Device at NPIAP 2024 Annual Conference on February 16

IR-MED Inc., (“IR-MED” or the “Company”) (OTCQB:IRME), developer of a noninvasive artificial intelligence (AI) driven spectrographic analysis technology platform to address significant healthcare needs, announced today that final data from a study conducted at two medical centers, Beit Rivka Hospital,…